Attached files

file filename
10-K - FORM 10-K - Bohai Pharmaceuticals Group, Inc.v324415_10k.htm
EX-32.1 - EXHIBIT 32.1 - Bohai Pharmaceuticals Group, Inc.v324415_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - Bohai Pharmaceuticals Group, Inc.v324415_ex31-1.htm

Exhibit 21.1


Subsidiaries of the Registrant


1.The Company’s wholly owned subsidiary, Chance High International Limited, a British Virgin Islands company (“Chance High”);


2.Chance High’s wholly owned subsidiary, YantaiShencaojishi Pharmaceuticals Co., Ltd., a PRC company (“WFOE”);


3.Chance High’s wholly owned subsidiary, YantaiNirui Pharmaceutical Co., Ltd., a PRC company (“WFOE II”);


4.the WFOE’s variable interest entity, YantaiBohai Pharmaceuticals Group Co., Ltd., a PRC company (“Bohai”), which is the Company’s  initial operating subsidiary; and


5.WFOE II’s wholly owned subsidiary, Yantai Tianzheng Pharmaceutical Co., Ltd., a PRC company (“Yantai Tianzheng”), which the Company acquired in August 2011 and is the Company’s second operating subsidiary.